NCT02362659View on ClinicalTrials.gov

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry

CompletedOBSERVATIONAL
Enrollment

514

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 15, 2018

Study Completion Date

November 15, 2018

Conditions
Non-valvular Atrial Fibrillation
Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02362659 - Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry | Biotech Hunter | Biotech Hunter